Karagün, Şebnem https://orcid.org/0000-0003-2339-1609
Nessar, Ahmet Zeki https://orcid.org/0000-0003-2985-0212
Yıldız, Hamza https://orcid.org/0009-0004-6478-813X
Dal, Yusuf https://orcid.org/0000-0001-7162-4644
Karaca, Sefanur Gamze https://orcid.org/0000-0003-1595-2621
Coşkun, Ayhan https://orcid.org/0000-0002-2887-9649
Article History
Received: 20 September 2025
Accepted: 30 January 2026
First Online: 4 February 2026
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki and relevant national regulations, including the Regulation on Clinical Trials of New Medicinal Products for Human Use (Official Gazette dated 27.05.2023, No. 32203). Ethical approval was obtained from the Institutional Review Board (IRB) of Mersin University Clinical Research Ethics Committee (Decision No: 2024/346). The study was designed as a retrospective cohort study using routinely collected clinical and laboratory data. All data were fully anonymized prior to analysis, and no identifying personal information was accessed or used. In accordance with the above regulation and national legislation, the requirement for obtaining informed consent was reviewed by the Institutional Review Board and deemed unnecessary, given the retrospective nature of the study and the use of anonymized data.
: Not applicable.
: The authors declare no competing interests.